Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metal Nanoparticles | 9 | 2017 | 186 | 1.480 |
Why?
|
| Gold | 10 | 2017 | 226 | 1.470 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 922 | 0.980 |
Why?
|
| Nanoparticles | 5 | 2016 | 518 | 0.840 |
Why?
|
| Nanocapsules | 2 | 2018 | 21 | 0.690 |
Why?
|
| Biosensing Techniques | 2 | 2016 | 119 | 0.540 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 172 | 0.510 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 77 | 0.500 |
Why?
|
| Annexin A2 | 1 | 2015 | 6 | 0.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 614 | 0.470 |
Why?
|
| Intracranial Embolism | 1 | 2015 | 39 | 0.460 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 96 | 0.450 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 126 | 0.440 |
Why?
|
| Oxidative Stress | 1 | 2016 | 296 | 0.440 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2017 | 84 | 0.360 |
Why?
|
| Peptides | 1 | 2014 | 574 | 0.350 |
Why?
|
| Receptors, Peptide | 2 | 2008 | 34 | 0.340 |
Why?
|
| Signal Recognition Particle | 2 | 2008 | 39 | 0.330 |
Why?
|
| Surface Properties | 6 | 2016 | 278 | 0.330 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2008 | 147 | 0.320 |
Why?
|
| Protein Sorting Signals | 1 | 2008 | 55 | 0.280 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2008 | 441 | 0.250 |
Why?
|
| Cytosol | 2 | 2018 | 179 | 0.250 |
Why?
|
| Stroke | 1 | 2015 | 1191 | 0.250 |
Why?
|
| Particle Size | 3 | 2016 | 407 | 0.240 |
Why?
|
| Fluorescein Angiography | 1 | 2024 | 58 | 0.220 |
Why?
|
| Retinal Diseases | 1 | 2024 | 33 | 0.210 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2008 | 559 | 0.210 |
Why?
|
| Staphylococcus aureus | 2 | 2014 | 176 | 0.200 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 223 | 0.180 |
Why?
|
| HeLa Cells | 3 | 2017 | 534 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 881 | 0.160 |
Why?
|
| Cations | 2 | 2015 | 64 | 0.150 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 54 | 0.140 |
Why?
|
| Static Electricity | 2 | 2015 | 167 | 0.140 |
Why?
|
| Boronic Acids | 1 | 2017 | 28 | 0.140 |
Why?
|
| CD47 Antigen | 1 | 2016 | 3 | 0.130 |
Why?
|
| Galactose | 1 | 2016 | 12 | 0.130 |
Why?
|
| Dendrimers | 1 | 2016 | 11 | 0.130 |
Why?
|
| Animals | 9 | 2018 | 20629 | 0.130 |
Why?
|
| Lasers | 1 | 2016 | 36 | 0.120 |
Why?
|
| Anions | 1 | 2015 | 33 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 88 | 0.120 |
Why?
|
| Paclitaxel | 1 | 2016 | 99 | 0.120 |
Why?
|
| Diffusion | 1 | 2015 | 82 | 0.120 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 114 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2018 | 399 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 48 | 0.120 |
Why?
|
| Brain Infarction | 1 | 2015 | 21 | 0.120 |
Why?
|
| Ligands | 1 | 2016 | 416 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2016 | 287 | 0.120 |
Why?
|
| Rats, Wistar | 1 | 2015 | 185 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2016 | 97 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 364 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2016 | 150 | 0.110 |
Why?
|
| Endocytosis | 1 | 2015 | 152 | 0.110 |
Why?
|
| Time Factors | 2 | 2015 | 3761 | 0.110 |
Why?
|
| Amino Acids | 1 | 2015 | 146 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 135 | 0.110 |
Why?
|
| Polylysine | 1 | 2014 | 49 | 0.110 |
Why?
|
| Polyamines | 1 | 2014 | 12 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 463 | 0.110 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 319 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 326 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2017 | 625 | 0.100 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 168 | 0.100 |
Why?
|
| Mice | 5 | 2018 | 10823 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 77 | 0.100 |
Why?
|
| Poaceae | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cucurbita | 1 | 2012 | 3 | 0.100 |
Why?
|
| Raphanus | 1 | 2012 | 4 | 0.100 |
Why?
|
| Melanoma | 1 | 2016 | 331 | 0.100 |
Why?
|
| Quantum Dots | 1 | 2012 | 30 | 0.100 |
Why?
|
| Ribosomes | 2 | 2005 | 163 | 0.090 |
Why?
|
| SEC Translocation Channels | 2 | 2008 | 38 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2008 | 895 | 0.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2008 | 134 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 784 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2008 | 166 | 0.070 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2008 | 127 | 0.070 |
Why?
|
| Brain | 1 | 2015 | 1555 | 0.060 |
Why?
|
| Protein Transport | 1 | 2008 | 401 | 0.060 |
Why?
|
| Spleen | 2 | 2017 | 483 | 0.060 |
Why?
|
| Female | 4 | 2024 | 32784 | 0.060 |
Why?
|
| Humans | 6 | 2024 | 63281 | 0.060 |
Why?
|
| Fundus Oculi | 1 | 2024 | 22 | 0.060 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2024 | 6 | 0.060 |
Why?
|
| Optic Nerve Diseases | 1 | 2024 | 18 | 0.060 |
Why?
|
| Visual Acuity | 1 | 2024 | 125 | 0.050 |
Why?
|
| Ischemia | 1 | 2024 | 204 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2003 | 173 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 459 | 0.050 |
Why?
|
| Liver | 2 | 2017 | 851 | 0.050 |
Why?
|
| Neoplasms | 1 | 2012 | 1358 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 863 | 0.040 |
Why?
|
| Mutation | 1 | 2008 | 2607 | 0.040 |
Why?
|
| Biological Transport | 2 | 2012 | 291 | 0.040 |
Why?
|
| Male | 2 | 2016 | 29817 | 0.040 |
Why?
|
| Injections | 1 | 2017 | 81 | 0.030 |
Why?
|
| Thiocarbamates | 1 | 2016 | 2 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 59 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 384 | 0.030 |
Why?
|
| Printing | 1 | 2015 | 21 | 0.030 |
Why?
|
| Arginine | 1 | 2016 | 124 | 0.030 |
Why?
|
| Phenotype | 2 | 2012 | 1199 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2014 | 59 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2014 | 55 | 0.030 |
Why?
|
| Adsorption | 1 | 2014 | 83 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 301 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 112 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 63 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 569 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2015 | 135 | 0.030 |
Why?
|
| Polyelectrolytes | 1 | 2014 | 7 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 371 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2014 | 270 | 0.030 |
Why?
|
| Hydroponics | 1 | 2012 | 4 | 0.030 |
Why?
|
| Plant Components, Aerial | 1 | 2012 | 6 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2013 | 293 | 0.020 |
Why?
|
| Kinetics | 1 | 2014 | 760 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2012 | 28 | 0.020 |
Why?
|
| MCF-7 Cells | 1 | 2012 | 69 | 0.020 |
Why?
|
| Plant Roots | 1 | 2012 | 63 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1177 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 334 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1464 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2107 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2180 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3391 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 14390 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1348 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2005 | 83 | 0.010 |
Why?
|
| Liposomes | 1 | 2005 | 107 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 166 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 300 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 260 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2003 | 59 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 325 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1592 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1990 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 1148 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1602 | 0.010 |
Why?
|
| Proteins | 1 | 2003 | 751 | 0.010 |
Why?
|